☆ 4.4 Letter

Activation state of platelets in experimental severe hemophilia A

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

Journal

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL

Volume 97, Issue 7, Pages 1115-1116

Publisher

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2012.065235

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency

Stacy E. Croteau, Andrew L. Frelinger, Anja J. Gerrits, Alan D. Michelson

Summary: Decreased platelet surface phosphatidylserine expression measured by annexin V binding predicts increased bleeding in severe FVIII deficient patients on prophylaxis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Hematology

Thromboelastography and thrombin generation assessments for pediatric severe hemophilia A patients are highly variable and not predictive of clinical phenotypes

Natalie Mathews, Fred G. Pluthero, Margaret L. Rand, Ann Marie Stain, Manuel Carcao, Victor S. Blanchette, Walter H. A. Kahr

Summary: In this study, baseline hemostatic activity was measured using CAT and TEG in a cohort of 30 pediatric SHA patients. The results showed concordance between the assays, but they were not predictive of FVIII requirements or correlated with other clinical parameters. This highlights the influence of factors other than baseline hemostatic activity in SHA patient heterogeneity.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Medicine, Research & Experimental

The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open-label, randomised controlled trial

Lieve Mees van Zijverden, Moya Henriette Schutte, Milou Cecilia Madsen, Tobias Nicolaas Bonten, Yvo Michiel Smulders, Chantal Maria Wiepjes, Jeske Joanna Katarina van Diemen, Abel Thijs

Summary: Patients with severe infection have an increased risk of cardiovascular events. A possible underlying mechanism is inflammation-induced platelet aggregation. This study investigated whether hyperaggregation occurs during infection, and whether aspirin inhibits this.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

Add to Collection

Article Veterinary Sciences

Hemophilia A Resulting in Severe Hyperesthesia Due to Extraparenchymal Spinal Cord Hemorrhage in a Young Golden Retriever Puppy

Charlotte Lubbers, Martijn Beukers, Niklas Bergknut, Geert Paes

Summary: This case report describes a case of spinal cord bleeding in a male Golden Retriever puppy caused by hemophilia A. The puppy presented with severe pain and mild hindlimb weakness. Diagnosis was made based on abnormal clotting test results and decreased factor VIII activity. Treatment was mainly supportive, as there is currently no cure for hemophilia A.

VETERINARY SCIENCES (2022)

Add to Collection

Article Orthopedics

Osteoporosis and associated risk factors in patients with severe hemophilia A: a case-control study from China

DongXiao Wu, ShaoNing Shen

Summary: Patients with severe hemophilia A have lower bone mineral density, especially in the hip, which is related to low BMI and decreased functional independence.

BMC MUSCULOSKELETAL DISORDERS (2023)

Add to Collection

Article Hematology

Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells

Weiqing Jing, Christina K. Baumgartner, Feng Xue, Jocelyn A. Schroeder, Qizhen Shi

Summary: In this study, we found that pre-existing inhibitors can lead to the loss of platelet-FVIII expression, and this loss is mediated by cytotoxic CD8 T cells. This finding is crucial for the treatment of hemophilia A patients with inhibitors.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Add to Collection

Article Surgery

Effectiveness of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting the incidence of nausea and vomiting after total knee arthroplasty in patients with hemophilia A

Denghe Feng, Dong Wang, Changping Gu, Meng Lv, Zaibo Liu, Yuelan Wang

Summary: This study investigated the predictive ability of preoperative neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for postoperative nausea and vomiting (PONV) after total knee arthroplasty (TKA). The results showed that preoperative NLR was an independent risk factor for PONV in patients with hemophilia A, and it significantly predicted the occurrence of PONV.

FRONTIERS IN SURGERY (2023)

Add to Collection

Article Hematology

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19

Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, Laura Michalick, Oleg Pak, Astrid-Solveig Schultz, Fabian Schramm, Martin Zacharias, Gregor Gorkiewicz, Sascha David, Tobias Welte, Julius J. Schmidt, Norbert Weissmann, Ralph T. Schermuly, Guillermo Barreto, Liliana Schaefer, Philipp Markart, Markus C. Brack, Stefan Hippenstiel, Florian Kurth, Leif E. Sander, Martin Witzenrath, Wolfgang M. Kuebler, Grazyna Kwapiszewska, Klaus T. Preissner

Summary: The altered levels of factor XII (FXII) and its activation products contribute to the high incidence of thrombotic events in COVID-19 patients. COVID-19 patients exhibit rapid consumption of FXII and no prolonged lag phase in fibrin formation triggered by the FXII activator kaolin, unlike patients with ARDS-influenza. Confocal and electron microscopy analysis show that COVID-19 patients form compact clots with thin fibers and small pores, leading to impaired clot lysis. Widespread compact fibrin deposits are observed in the lung tissue of COVID-19 patients.

BLOOD ADVANCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Microvascular Thrombosis as a Critical Factor in Severe COVID-19

Patricia P. Wadowski, Benjamin Panzer, Alicja Jozkowicz, Christoph W. Kopp, Thomas Gremmel, Simon Panzer, Renate Koppensteiner

Summary: Platelet-endothelial interactions play a crucial role in microcirculatory function and tissue homeostasis. COVID-19 disrupts the delicate balance between platelets and the vessel wall, leading to endothelial damage, microthrombosis, and tissue ischemia. In this opinion paper, we discuss the pathological processes that contribute to endothelial activation and thrombus formation, which may drive the deterioration of severe COVID-19 cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Medicine, Research & Experimental

In vitro antiplatelet activity of extract and its fractions of Paulownia Clone in Vitro 112 leaves

Weronika Adach, Jerzy Zuchowski, Barbara Moniuszko-Szajwaj, Malgorzata Szumacher-Strabel, Anna Stochmal, Beata Olas, Adam Cieslak

Summary: Paulownia Clone in Vitro 112 leaves are a new valuable source of compounds with antiplatelet potential, with verbascoside being the main secondary metabolite in the extract and demonstrating stronger antiplatelet properties than the fractions. This suggests that the leaves of this plant may serve as a potential source of antiplatelet compounds.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Cell Biology

PIEZO1 mediates a mechanothrombotic pathway in diabetes

Wandi Zhu, Shihui Guo, Max Homilius, Cissy Nsubuga, Shane H. Wright, Dajun Quan, Ashmita Kc, Samuel S. Eddy, Rachelle A. Victorio, Manu Beerens, Robert Flaumenhaft, Rahul C. Deo, Calum A. MacRae

Summary: This study identified dysregulation of the mechanosensory ion channel Piezo1 in platelets, red blood cells, and neutrophils of patients with type 2 diabetes mellitus (T2DM), leading to prothrombotic cellular responses. Inhibition of Piezo1 protected against thrombosis, providing a new target for modulating T2DM-related thrombosis.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Oncology

Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia

Courtney D. Thornburg, Dana H. Simmons, Annette von Drygalski

Summary: Hemophilia is a disorder characterized by a deficiency in coagulation factors VIII or IX, and the standard treatment involves regular intravenous factor replacement. However, this treatment is burdensome for patients and nonadherence can lead to severe bleeding. Gene therapies, such as valoctocogene roxaparvovec and etranacogene dezaparvovec-drlb, offer a promising alternative by reducing treatment burden and eliminating the need for frequent factor replacement. However, monitoring liver health and long-term safety and efficacy are important considerations for these therapies.

BIODRUGS (2023)

Add to Collection

Article Hematology

Inter-individual variability in pharmacokinetics and clinical features in pediatric patients with severe hemophilia A

Kun Huang, Yan Wang, Yingzi Zhen, Gang Li, Xinyi Wu, Ningning Zhang, Zhenping Chen, Runhui Wu

Summary: This study revealed significant inter-individual variability in PK parameters, clinical bleeding phenotype, and joint vulnerability in patients with severe hemophilia A, highlighting the importance of considering these factors in the treatment of the disease.

THROMBOSIS RESEARCH (2022)

Add to Collection

Article Allergy

Deciphering the role of platelets in severe allergy by an integrative omics approach

Carmela Pablo-Torres, Elena Izquierdo, Tiak Ju Tan, David Obeso, Janice A. Layhadi, Javier Sanchez-Solares, Leticia Mera-Berriatua, Jose Luis Bueno-Cabrera, Maria del Mar Reano-Martos, Alfredo Iglesias-Cadarso, Coral Barbas, Cristina Gomez-Casado, Alma Villasenor, Domingo Barber, Mohamed H. Shamji, Maria M. Escribese

Summary: Platelet lipidomics, RNA-seq analysis, and protein quantification were used to compare platelet profiles between severe allergic patients, mild allergic patients, and nonallergic subjects. The results showed significant differences in lipid, mRNA, and protein content, suggesting that platelets may serve as potential biomarkers and therapeutic targets for severe inflammatory pathologies.

ALLERGY (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia

Hugo Ribeiro, Raquel Alves, Joana Jorge, Ana Cristina Goncalves, Ana Bela Sarmento-Ribeiro, Manuel Teixeira-Verissimo, Marilia Dourado, Jose Paulo Andrade

Summary: This study found that certain membrane platelet proteins may serve as biomarkers for pain characterization. These biomarkers, including CD40, CD49f, CD62p, and CD61, can provide objective information about pain levels without relying on patient self-report. The identification of these biomarkers could lead to more effective pain management strategies.

BIOMEDICINES (2023)

Add to Collection

Article Cell Biology

Intravenous abciximab as a rescue therapy for immediate reocclusion after successful mechanical thrombectomy in acute ischemic stroke patients

Francois Delvoye, Stephane Loyau, Julien Labreuche, Guillaume Taylor, Benjamin Maier, Michel Piotin, Raphael Blanc, Simon Escalard, Lucas Di Meglio, Malek Ben Maacha, Hocine Redjem, Stanislas Smajda, Gabriele Ciccio, Solene Hebert, Candice Sabben, Martine Jandrot-Perrus, Alain Maertens De Noordhout, Mikael Mazighi, Benoit Ho-Tin-Noe, Jean-Philippe Desilles

Summary: This study investigated the use of the glycoprotein IIb/IIIa antagonist abciximab in treating immediate reocclusion after mechanical thrombectomy for acute ischemic stroke. The results showed that abciximab treatment led to higher recanalization rates without increasing bleeding complications. In vitro experiments further demonstrated that abciximab effectively limits thrombus accretion by blocking platelet aggregation.

PLATELETS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

Waltraud C. Schrottmaier, Anita Pirabe, David Pereyra, Stefan Heber, Hubert Hackl, Anna Schmuckenschlager, Laura Brunnthaler, Jonas Santol, Kerstin Kammerer, Justin Oosterlee, Erich Pawelka, Sonja M. Treiber, Abdullah O. Khan, Matthew Pugh, Marianna T. Traugott, Christian Schoergenhofer, Tamara Seitz, Mario Karolyi, Bernd Jilma, Julie Rayes, Alexander Zoufaly, Alice Assinger

Summary: Anticoagulation is associated with reduced mortality in COVID-19, but the role of antiplatelet therapy remains unclear. Adverse outcome in COVID-19 is related to dysregulation of the coagulation system, but the contribution of platelets to thrombotic complications is still uncertain.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Editorial Material Hematology

It talees guts to boost platelet reactivity and inflammation

Julie Rayes

Summary: The intestinal IL-33-ST2-serotonin axis plays a key role in immune-endocrinal crosstalk during hemostasis and platelet-dependent neutrophil recruitment during inflammation.

BLOOD (2022)

Add to Collection

Editorial Material Hematology

GPVI and collagen: the final word?

Alexandre Slater, Martine Jandrot-Perrus

Summary: The authors of this study report the structure of platelet glycoprotein VI complexed with collagen-related peptides and propose the structural basis of GPVI clustering on collagen fibers.

BLOOD (2022)

Add to Collection

Review Hematology

Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation

Shruti Raghunathan, Julie Rayes, Anirban Sen Gupta

Summary: Platelets, derived from megakaryocytes, play a vital role in hemostasis and can be used as a platform for disease-targeted drug delivery. Platelet defects can lead to bleeding complications, while platelet-inspired technologies have the potential to improve therapeutic efficacy.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature

Abdullah O. Khan, Jasmeet S. Reyat, Harriet Hill, Joshua H. Bourne, Martina Colicchia, Maddy L. Newby, Joel D. Allen, Max Crispin, Esther Youd, Paul G. Murray, Graham Taylor, Zania Stamataki, Alex G. Richter, Adam F. Cunningham, Matthew Pugh, Julie Rayes

Summary: This study found that the interaction between pericytes and endothelial cells is disrupted in COVID-19 infection, leading to increased microvascular endothelial permeability, which may result in thrombotic and bleeding complications.

CARDIOVASCULAR RESEARCH (2022)

Add to Collection

Article Hematology

CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear

Joshua H. Bourne, Christopher W. Smith, Natalie J. Jooss, Ying Di, Helena C. Brown, Samantha J. Montague, Mark R. Thomas, Natalie S. Poulter, Julie Rayes, Steve P. Watson

Summary: C-type lectin-like receptor 2 (CLEC-2) is highly expressed on platelets and plays a critical role in lymphatic development. This study demonstrates that CLEC-2 supports thrombus formation at sites of inflammation without affecting hemostasis. It suggests that CLEC-2 could be a promising therapeutic target for thromboinflammatory disorders.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Immunology

SARS-CoV-2 Spike- and Nucleoprotein-Specific Antibodies Induced After Vaccination or Infection Promote Classical Complement Activation

Rachel E. Lamerton, Edith Marcial-Juarez, Sian E. Faustini, Marisol Perez-Toledo, Margaret Goodall, Sian E. Jossi, Maddy L. Newby, Iain Chapple, Thomas Dietrich, Tonny Veenith, Adrian M. Shields, Lorraine Harper, Ian R. Henderson, Julie Rayes, David C. Wraith, Steve P. Watson, Max Crispin, Mark T. Drayson, Alex G. Richter, Adam F. Cunningham

Summary: This study investigates the interaction between SARS-CoV-2 antibodies and complement activation using an ELISA assay. The results suggest that the downstream effects of antibody-dependent complement activation may vary depending on the disease status and the specific antigen targeted.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Hematology

S100A8/A9 drives the formation of procoagulant platelets through GPIbα

Martina Colicchia, Waltraud C. Schrottmaier, Gina Perrella, Jasmeet S. Reyat, Jenefa Begum, Alexandre Slater, Joshua Price, Joanne C. Clark, Zhaogong Zhi, Megan J. Simpson, Joshua H. Bourne, Natalie S. Poulter, Abdullah O. Khan, Phillip L. R. Nicolson, Matthew Pugh, Paul Harrison, Asif J. Iqbal, George E. Rainger, Steve P. Watson, Mark R. Thomas, Nicola J. Mutch, Alice Assinger, Julie Rayes

Summary: S100A8/A9, secreted by activated myeloid cells, has antimicrobial, proinflammatory, and prothrombotic properties. Increased levels of S100A8/A9 in COVID-19 patients are associated with poor outcomes. S100A8/A9 is mainly detected in neutrophils and deposited on vessel walls in COVID-19 lungs. Platelets interact with S100A8/A9, leading to the formation of procoagulant platelets.

BLOOD (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1

Ilaria De Simone, Constance C. F. M. J. Baaten, Martine Jandrot-Perrus, Jonathan M. Gibbins, Hugo ten Cate, Johan W. M. Heemskerk, Chris Jones, Paola E. J. van der Meijden

Summary: Platelet and coagulation activation are reciprocal processes, and factors other than thrombin or fibrin can induce platelet activation via GPVI and PAR receptors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Hematology

A gain-of-function filamin A mutation in mouse platelets induces thrombus instability

Frederic Adam, Alexandre Kauskot, Lamia Lamrani, Jean Solarz, Christelle Soukaseum, Christelle Reperant, Cecile Denis, Hana Raslova, Jean-Philippe Rosa, Marijke Bryckaert

Summary: This study investigates the thrombotic potential of a male patient with a FLNa mutation in an in vivo model. They establish a mutant FlnA knock-in mouse model which phenocopies the patient's platelets showing increased platelet functions in vitro. However, in vivo, the mutant FlnA mice exhibit thrombus instability evidenced by increased re-bleeding and arteriolar embolies.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Immunology

Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation

Olga Krysko, Joshua H. Bourne, Elena Kondakova, Elena A. Galova, Katharine Whitworth, Maddy L. Newby, Claus Bachert, Harriet Hill, Max Crispin, Zania Stamataki, Adam F. Cunningham, Matthew Pugh, Abdullah O. Khan, Julie Rayes, Maria Vedunova, Dmitri V. Krysko, Alexander Brill

Summary: This study found a strong association between SARS-CoV-2 infection and activation of mast cells (MC), which is likely driven by the inflammatory response. The levels of MC proteases were increased in the serum of COVID-19 patients and correlated with disease severity. The results suggest that MC protease levels could predict the course of the disease and that including MC-stabilizing drugs in the treatment scheme might be beneficial for severe COVID-19 patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Oncology

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies

Abdullah O. Khan, Antonio Rodriguez-Romera, Jasmeet S. Reyat, Aude-Anais Olijnik, Michela Colombo, Guanlin Wang, Wei Xiong Wen, Nikolaos Sousos, Lauren C. Murphy, Beata Grygielska, Gina Perrella, Christopher B. Mahony, Rebecca E. Ling, Natalina E. Elliott, Christina Simoglou Karali, Andrew P. Stone, Samuel Kemble, Emily A. Cutler, Adele K. Fielding, Adam P. Croft, David Bassett, Gowsihan Poologasundarampillai, Anindita Roy, Sarah Gooding, Julie Rayes, Kellie R. Machlus, Bethan Psaila

Summary: This study presents a human bone marrow organoid that can support the growth and survival of primary cells from patients with myeloid and lymphoid blood cancers. This organoid model allows for mechanistic studies of blood cancers within their microenvironment and serves as an ex vivo tool for prioritizing new therapeutics.

CANCER DISCOVERY (2023)

Add to Collection

Review Hematology

Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation

Jordan D. D. Dimitrov, Lubka T. T. Roumenina, Gina Perrella, Julie Rayes

Summary: Regardless of the cause, hemolytic diseases are associated with thrombosis, inflammation, and immune dysregulation, resulting in organ damage and poor outcomes. Hemolysis not only leads to anemia and loss of the anti-inflammatory functions of red blood cells, but also releases damage-associated molecular patterns, such as ADP, hemoglobin, and heme, which trigger a hyperinflammatory and hypercoagulable state through various receptors and signaling pathways. Extracellular free heme, in particular, can activate platelets, endothelial cells, innate cells, as well as the coagulation and complement cascades, thereby promoting thrombo-inflammatory events. This review discusses the main mechanisms by which hemolysis, especially heme, drives this thrombo-inflammatory environment and explores the impact of hemolysis on the host response to secondary infections.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Add to Collection

Article Hematology

Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models

Stephanie Roullet, Norman Luc, Julie Rayes, Jean Solarz, Dante Disharoon, Andrew Ditto, Emily Gahagan, Christa Pawlowski, Thibaud Sefiane, Frederic Adam, Caterina Casari, Olivier D. Christophe, Michael Bruckman, Peter J. Lenting, Anirban Sen Gupta, Cecile Denis

Summary: The lack of innovation in von Willebrand disease (VWD) is due to the complexity and heterogeneity of the disease and a lack of recognition of the impact of bleeding symptoms experienced by patients. This study proposes a new approach using synthetic platelet (SP) nanoparticles for the treatment of VWD-2B and severe VWD. The results show that SP can improve thrombus formation and reduce blood loss in VWD-2B and VWF-KO mice.

BLOOD (2023)

Add to Collection

No Data Available

Activation state of platelets in experimental severe hemophilia A

Journal

Publisher

FERRATA STORTI FOUNDATION

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper